TEVA – teva pharmaceutical industries limited american depositary shares (US:NASDAQ)
Stock Stats
News
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $36.00 to $45.00. They now have a "buy" rating on the stock.
Is Teva Pharmaceutical Industries Limited (TEVA) an Undervalued Stock Relative to Its Long-Term Potential? [Yahoo! Finance]
Barclays Raises Teva Pharmaceutical (TEVA) PT to $38 Following Strong Q4 Earnings Beat [Yahoo! Finance]
Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory [Yahoo! Finance]
Jim Cramer Highlights Teva Pharmaceutical's Growth Under CEO Richard Francis [Yahoo! Finance]
Form SCHEDULE 13G/A TEVA PHARMACEUTICAL INDU Filed by: Harel Insurance Investments & Financial Services Ltd.
Form 10-K TEVA PHARMACEUTICAL INDU For: Dec 31
Form 4 TEVA PHARMACEUTICAL INDU For: Jan 27 Filed by: Kalif Eliyahu Sharon
Form 4 TEVA PHARMACEUTICAL INDU For: Jan 27 Filed by: Hughes Eric A
Form 4 TEVA PHARMACEUTICAL INDU For: Jan 27 Filed by: Sabag Mark
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.